Rosacea: Pathophysiology and Treatment

Archives of Dermatology

Volumn 130, Issue 3, 1994, Pages 359-362

  Wilkin, Jonathan K ^a  

^a 4731 University Hospitals Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN; METRONIDAZOLE; RETINOIC ACID; TETRACYCLINE;

ANGIOGENESIS; DRUG HYPERSENSITIVITY; EDITORIAL; ERYTHEMA; FACE EDEMA; FLUSHING; HUMAN; LYMPHATIC SYSTEM; ORAL DRUG ADMINISTRATION; PAPULE; PRIORITY JOURNAL; PUSTULE; ROSACEA; TELANGIECTASIA; TOPICAL DRUG ADMINISTRATION;

ACNE ROSACEA; ADULT; FEMALE; HUMAN; REGIONAL BLOOD FLOW; SKIN; TRETINOIN;

EID: 0028294558     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1994.01690030091015     Document Type: Article

References (45)

1. 1. Burton JL. The logic of dermatological diagnosis. Clin Exp Dermatol. 1981; 6: 1-21.
2. 2. Wilkin JK. Flushing reactions: consequences and mechanisms. Ann Intern Med. 1981; 95: 468-476.
3. 3. Marks R, Beard RJ, Clark ML, Kwok M, Robertson WB. Gastrointestinal observations in rosacea. Lancet. 1967; 1: 739-743.
4. 4. Starr PAJ, Macdonald A. Oculocutaneous aspects of rosacea. Proc R Soc Med. 1969; 62: 9-11.
5. 5. Tassi G, De Nicola P. CDP-choline and xanthinol nicotinate: study of conjunctival microcirculation, of platelet aggregation, and of lipidic fractions. Curr Ther Res. 1981; 30: 98-106.
6. 6. Findlay GH, Simson IW. Leonine hypertrophic rosacea associated with a benign bronchial carcinoid tumor. Clin Exp Dermatol. 1977; 2: 175-176.
7. 7. Calvert HT, Karlish AJ, Wells RS. Bronchial adenoma with the carcinoid syndrome presenting with unusual skin changes. Postgrad Med J. 1963; 39: 547-550.
8. 8. Mattingly TW. The functioning carcinoid tumor: new clinical entity. Med Ann DC. 1956; 25: 304-312, 355-356.
9. 9. Wilkin JK. Rapidly progressive rosacea in an adult male with flushing attacks, pruritus, and ‘freckles.’ Contemp Intern Med. 1991; 3: 150-160.
10. 10. Plewig G, Kligman AM. Acne: Morphogenesis and Treatment. New York, NY: Springer-Verlag NY Inc; 1975: 261.
11. 11. MacKenna RMB. Rosacea. Practitioner. 1958; 180: 533-542.
12. 12. Wilkin JK. Oral thermal-induced flushing in erythematotelangiectatic rosacea. J Invest Dermatol. 1981; 76: 15-18.
13. 13. Domonkos AN. Andrews’ Diseases of the Skin. Philadelphia, Pa: WB Saunders Co; 1971: 261.
14. 14. Wilkin JK. Vasodilator rosacea. Arch Dermatol. 1980; 116: 598.
15. 15. Wilkin JK. Why is flushing limited to a mostly facial cutaneous distribution? J Am Acad Dermatol. 1988; 19: 309-313.
16. 16. Van Duyn J. Lymphedema in face scars. South Med J. 1969; 62: 1149-1150.
17. 17. Marks R. Common Facial Dermatoses. Littleton, Mass: John Wright-PSG Inc; 1976; 12.
18. 18. Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol. 1968; 80: 170-177.
19. 19. Sobye P. Aetiology and pathogenesis of rosacea. Acta Derm Venereol. 1950; 30: 137-140.
20. 20. Tsvetkova GM, Ryzhova El, Lyagushkina MP. Klinikomorphologicheskie issledovaniya kozhi bolnykh v razlichnykh stadiyakh rozatsea. Vestn Dermatol Venerol. 1977; 12: 12-17.
21. 21. Mortimer PS, Simmonds R, Rezvani M, Robbins M, Hopewell JW, Ryan TJ. The measurement of skin lymph flow by isotope clearance: reliability, reproducibility, injection dynamics, and the effect of massage. J Invest Dermatol. 1990; 95: 677-682.
22. 22. Wilkin JK. Epigastric rosacea. Arch Dermatol. 1980; 116: 584.
23. 23. Schirger A, Peterson LFA. Lymphedema. In: Peripheral Vascular Diseases. Philadelphia, Pa: WB Saunders Co; 1972: 644.
24. 24. Penneys NS. Factor XIII expression in the skin: observations and a hypothesis. J Am Acad Dermatol. 1990; 22: 484-488.
25. 25. Ryan TJ. Biochemical consequences of mechanical forces generated by distention and distortion. J Am Acad Dermatol. 1989; 21: 115-130.
26. 26. Ryan TJ. Structure and function of lymphatics. J Invest Dermatol. 1989; 93: 18S-24S.
27. 27. Haxthausen H. Changes in the skin-vessels from protracted action of climatic factors and their significance in various skin diseases. Br J Dermatol. 1930; 42: 105-125.
28. 28. Rice WG, Weiss SJ. Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science. 1990; 249: 178-181.
29. 29. West JB, Mathieu-Costello O. Stress failure of pulmonary capillaries: role in lung and heart disease. Lancet. 1992; 340: 762-767.
30. 30. Duvanel T, Auckenthaler R, Rohner P, Harms M, Saurat JH. Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med. 1989; 149: 293-296.
31. 31. Motley RJ, Barton S, Marks R. The significance of telangiectasia in rosacea. In: Acne and Related Disorders: An International Symposium. Cardiff, Wales: Martin Dunitz; 1989: 339-344.
32. 32. Lowe NJ, Behr KL. Fitzpatrick R, Goldman M, Ruiz-Esparza J. Flash lamp pumped dye laser for rosacea-associated telangiectasia and erythema. J Dermatol Surg Oncol. 1991; 17: 522-525.
33. 33. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992; 258: 1798-1801.
34. 34. Dyson M, Young SR, Hart J, Lynch JA, Lang S. Comparison of the effects of moist and dry conditions on the process of angiogenesis during dermal repair. J Invest Dermatol. 1992; 99: 729-733.
35. 35. Logan A. Angiogenesis. Lancet. 1993; 341: 1467-1468.
36. 36. Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol. 1989; 69: 419-423.
37. 37. Wen CP, Tsai SP, Gibson RL. Anatomy of the healthy worker effect: a critical review. J Occup Med. 1983; 25: 283-289.
38. 38. Bleicher PA, Charles JH, Sober AJ. Topical metronidazole therapy for rosacea. Arch Dermatol. 1987; 123: 609-614.
39. 39. Knight AG, Vickers CFH. A follow-up of tetracycline-treated rosacea. Br J Dermatol. 1975; 93: 577-580.
40. 40. Griffiths CEM, Russman AN, Majmudar G, Singer RS, Hamilton TA, Voorhees JJ. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med. 1993; 329: 530-535.
41. 41. Marks R, Harcourt-Webster JN. Histopathology of rosacea. Arch Dermatol. 1969; 100: 683-692.
42. 42. Kligman AM, Dogadkina D, Lavker RM. Effects of topical tretinoin on non-sun-exposed protected skin of the elderly. J Am Acad Dermatol. 1993; 29: 25-33.
43. 43. Weiss JS, Ellis CN, Headington JT, Tincoff T, Hamilton TA, Voorhees JJ. Topical tretinoin improves photoaged skin. JAMA. 1988; 259: 527-532.
44. 44. Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol. 1994; 130: 319-324.
45. 45. Verbenko YV, Katsman LY. Opyt lecheniya vulgarnykh i rozovykh ugrey retinom-A. Vestn Dermatol Venerol. 1977; 2: 47-50.